TGFB2 and glioblastoma: We compared the survival outcomes of pediatric GBM patients whose TGFB2 mRNA expression levels were greater than or equal to the upper quartile (TGFB2high) to the treatment outcomes of the remaining pediatric GBM patients (TGFB2low).